Next |
home / stock / alpmy / alpmy message board
Subject | By | Source | When |
---|---|---|---|
$ALPMY Lets go go go go... Up up and away we go. | SPORT19 | investorshub | 07/02/2023 2:22:09 PM |
bears and bulls | jtrenee89 | investorshub | 07/01/2023 10:34:52 PM |
Thoughts on where this is headed? | rdfdr1 | investorshub | 06/29/2023 4:31:26 PM |
bears and bulls | Sam0 | investorshub | 06/27/2023 3:56:52 AM |
$ALPMY and the shorts continue | johnsyn | investorshub | 06/22/2023 2:00:01 PM |
$ALPMY Looks pretty positive | rdfdr1 | investorshub | 06/21/2023 4:39:49 AM |
$ALPMY Price trading | johnsyn | investorshub | 06/16/2023 5:57:43 PM |
what does this mean? | SPORT19 | investorshub | 06/16/2023 9:39:58 AM |
$ALPMY When is this gonna take off? | mlkrborn | investorshub | 06/16/2023 1:05:33 AM |
$ALPMY MomentumIts trading last trade up | surf1944 | investorshub | 06/15/2023 3:31:19 PM |
$ALPMY The trading | kyrie717 | investorshub | 06/09/2023 12:33:03 PM |
$ALPMY oh yeah news for the day | johnsyn | investorshub | 06/07/2023 2:36:29 AM |
whytestocks: $ALPMY News Article - Astellas to Present Findings from Phase 3 Long-Term Safety Study | whytestocks | investorshangout | 10/12/2022 12:10:55 PM |
whytestocks: $ALPMY News Article - Here's What Recent News From the FDA Means for AstraZeneca | whytestocks | investorshangout | 08/20/2021 12:50:48 PM |
whytestocks: $ALPMY News Article - U.S. FDA Grants Regular Approval and Expands Indication for PADCE | whytestocks | investorshangout | 07/09/2021 6:35:50 PM |
SPORT19, thanks for the Astellas link. I | scoobey-do | investorshub | 01/02/2021 5:16:06 PM |
One week ago ProtoKinetix $CEO Clarence Smith posted | SPORT19 | investorshub | 01/02/2021 4:36:52 PM |
Astellas Innovation Management ($AIM) sounds like a partnership | SPORT19 | investorshub | 01/02/2021 4:35:34 PM |
Heres another MUST WATCH Astellas Institute of Regenerative | SPORT19 | investorshub | 01/02/2021 4:34:08 PM |
Astellas has undergone a MASSIVE expansion of its | SPORT19 | investorshub | 01/02/2021 4:33:09 PM |
News, Short Squeeze, Breakout and More Instantly...
Astellas Pharma Inc. ADR Company Name:
ALPMY Stock Symbol:
OTCMKTS Market:
Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology PR Newswire - Leverages Poseida's proprietary allogeneic CAR-T platform to develop innovative convertibleCAR ® programs tar...
Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting PR Newswire XTANDI is now the first and only novel hormone therapy available for the treatment of high-risk biochemical recurr...